19
December 2024
Marechale Capital
plc
("Marechale Capital",
“Marechale” or the
"Company")
Half-yearly
Results
Marechale Capital plc, an
established City of London based
corporate finance house with a long-term track record and a strong
reputation for advising and financing high growth consumer brands,
leisure, clean energy, mineral extraction and technology companies,
announces its unaudited half-yearly results for the six months
ended 31 October 2024 (the
“Period”).
Chairman’s
Statement
Following the announcement
with Marechale’s full year results released in August 2024, the market continues to remain
challenging, particularly in the hospitality
sector.
During the six months
ended 31 October 2024, the Company
generated gross profits of £103,468 (2023: £93,813) and delivered
an operating loss of £138,485 (2023: loss of £155,421 ), resulting
in an overall loss before tax of £178,261 (2023: loss of
£155,803).
The Company’s balance
sheet shows a net asset value of £3,183,537 (2023: £3,340,486 ),
representing 3.01p (2023: 3.15p) of value per share in issue. The
Company remains positive about the investments that it holds in its
client companies.
Marechale Capital
continues to see interesting corporate finance and advisory
projects where it can take founders shares and warrants as part of
its advisory fees. On a positive note, Marechale has completed
transactions during the period for Weardale Lithium, Forest Road
Brewery, Stubben Edge and Chestnut Inns. However, the market
remains a difficult environment in which to raise capital. This has
resulted in some advisory projects that launched in the summer not
being completed by the end of the Period which includes a major UK
hotel group and a leading brewery and pub group. Marechale
continues to look for new and strategic funding partners alongside
its traditional investor
relationships.
The Board is working on a
number of initiatives to create further value for shareholders over
and above its core investment portfolio and corporate finance
projects, including working with various potential businesses and
individuals. The plan is to continue to develop Marechale’s
strategic partnerships with the objective of enhancing shareholder
value.
Marechale also uses its
balance sheet to co-invest in its client companies, along with
warrants and founder equity. Furthermore, the Board is able to
announce a partial realisation of £109,000 for cash on two of the
Company’s investments. Cash at bank at 31
October 2024 was £223,700.
Whist the current economic
climate is difficult, Marechale Capital remains diligent and is
convinced that there will be good advisory and investment
opportunities in its core hospitality, renewable, clean energy and
technology sectors over the short to medium
term.
Mark
Warde-Norbury
Chairman
The information
communicated in this announcement contains inside information for
the purposes of Article 7 of the Market Abuse Regulation (EU) No.
596/2014
For further information
please contact:
Marechale
Capital
Mark Warde-Norbury /
Patrick Booth-Clibborn
|
Tel: +44 (0)20 7628
5582
|
Cairn Financial Advisers
LLP
Jo Turner / Sandy
Jamieson
|
Tel: +44
(0)20 7213
0880
|
Income Statement
(unaudited) |
|
|
|
|
6 months ended 31
October |
|
|
|
2024 |
|
2023 |
|
|
|
|
|
£ |
|
|
|
Revenue |
|
|
|
148,500 |
|
320,603 |
|
Cost of
sales |
|
|
|
(45,032) |
|
(226,790) |
|
|
|
|
|
|
|
|
|
Gross
profit |
|
|
|
103,468 |
|
93,813 |
|
|
|
|
|
|
|
|
|
Administrative
expenses |
|
|
(241,953) |
|
(249,235) |
|
|
|
|
|
|
|
|
|
|
Operating
loss |
|
|
(138,485) |
|
(155,421) |
|
|
|
|
|
|
|
|
|
|
Exceptional
credit |
|
|
|
10,316 |
|
- |
|
Loss on disposal of
investments |
|
|
|
(49,837) |
|
|
|
Interest
paid |
(255) |
|
(382) |
|
|
|
|
|
|
|
|
|
(Loss)/profit before
tax |
|
|
|
(178,261) |
|
(155,803) |
|
Taxation |
|
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
(Loss)/profit
after tax |
|
|
|
(178,261) |
|
(155,803) |
|
|
|
|
|
|
(Loss)/profit per
share |
|
|
|
|
|
|
|
|
|
|
|
(Pence) |
|
(Pence) |
|
|
-
Basic |
|
(0.17) |
|
(0.15) |
|
|
-
Diluted |
|
|
(0.17) |
|
(0.14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet
(unaudited) |
|
|
|
|
|
|
|
As
at |
|
|
|
|
31
October |
31
October |
|
|
|
|
|
|
2024 |
2023 |
|
Current
assets |
|
|
|
|
|
|
|
Available for sale
investments |
|
|
2,939,660 |
2,863,227 |
|
Trading
investments |
|
|
|
49,953 |
130,076 |
|
Trade and other
receivables |
|
|
52,856 |
37,219 |
|
Cash and cash
equivalents |
|
|
223,712 |
398,229 |
|
|
|
|
|
|
3,266,181 |
3,428,751 |
|
|
|
|
|
|
|
|
|
Current
liabilities |
|
|
|
|
|
|
Trade and other
payablesPAYEBounce-back
Loan |
|
|
|
(54,338)(10,806)(10,000) |
(51,278)(9,847)(10,000) |
|
|
|
|
|
|
|
|
|
Total current
liabilities |
|
|
|
(75,144) |
(70,765) |
|
|
|
|
|
|
|
|
|
Net current
assets |
|
|
|
|
3,191,037 |
3,357,986 |
|
|
|
|
|
|
|
|
|
Bounce-back Loan –
long-term |
|
|
|
|
(7,500) |
(17,500) |
|
|
|
|
|
|
|
|
|
Net
assets |
|
|
|
|
3,183,537 |
3,340,486 |
|
Equity |
|
|
|
|
|
|
|
Capital and reserves
attributable to equity
shareholders |
|
|
|
Share
capitalShare
premium |
|
|
|
|
847,530481,290 |
847,530481,290 |
|
Reserve for own
shares |
|
|
|
(50,254) |
(50,254) |
|
Retained profits/
(losses) |
|
|
|
1,739,397 |
1944,842 |
|
Reserve for share based
payments |
|
|
|
165,574 |
117,078 |
|
|
|
|
|
3,183,537 |
3,340,486 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow
Statement (unaudited) |
|
|
|
|
6 months
ended |
31
October |
31
October |
|
|
|
|
|
|
2024 |
2023 |
|
|
|
|
|
|
£ |
£ |
|
Net cash from
operating activities |
|
|
|
|
|
Loss after
tax |
|
(178,261) |
(155,803) |
|
Reverse exceptional
credits |
|
|
(10,316) |
- |
|
Loss of disposal of
investments |
|
|
49,837 |
|
|
Provision for share based
paymentsReverse interest
paid |
|
|
15,406255 |
33,091381 |
|
|
|
|
|
|
|
|
|
Operating cash
flows before movements in working
capital |
(123,079) |
(122,331) |
|
|
|
|
|
|
|
|
|
Movement in
working capital |
|
|
|
|
|
(Increase)/ decrease in
receivables |
|
|
(7,950) |
38,714 |
|
Increase/ (decrease) in
payables |
|
|
3,108 |
(30,795) |
|
|
|
|
|
|
|
|
|
Net movement in
working capital |
|
|
|
|
(4,842) |
7,919 |
|
|
|
|
|
|
|
|
Operating cash
out-flow |
|
|
|
(127,921) |
(114,412) |
|
|
|
|
|
|
|
|
|
Investment
activities |
|
|
|
|
|
|
Expenditure on available
for sale investments |
- |
572 |
|
Proceeds from sale of
investments and options |
|
|
|
|
108,692 |
- |
|
|
|
|
|
|
|
|
|
Cash flow from
investing activities |
|
|
108,692 |
(572) |
|
|
|
|
|
|
|
|
|
FinancingShare
CapitalBounce-back Loan
repaymentsInterest
paidNet
financing |
|
|
|
-(5,000)(255)(5,255) |
235,800(5,000)(381)230,419 |
|
Net (decrease)/
increase in cash and cash
equivalents |
|
(24,484) |
115,435 |
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents at start of the
period |
248,196 |
282,794 |
|
Cash and cash
equivalents at end of the
period |
223,712 |
398,229 |
|
|
|
|
|
|
|
|
|
(Decrease)/
increase in cash and cash
equivalents |
|
(24,484) |
115,435 |
|
This financial information
has been prepared in accordance with IFRS and International
Financial Reporting Interpretations Committee ('IFRIC')
interpretations adopted by the European Union, and with those parts
of the Companies Act 2006 applicable to companies reporting under
IFRS, with the prior period being reported on the same
basis.